Breadcrumb
RI-MUHC researcher Dr. Madhukar Pai is focused on global efforts to improve TB diagnosis and end TB
Equity, Diversity and Inclusion (EDI) at the RI-MUHCAt the Research Institute of the McGill University Health Centre (RI-MUHC), we are...
RI-MUHC ANNUAL REPORT 2021
FOCUS ON OUR TRAINEESWHAT IS OUR NEW GENERATION OF RESEARCHERS ACHIEVING TODAY?Over 1,200 research trainees play...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWINJURY REPAIR RECOVERY (IRR) PROGRAMRESEARCH HIGHLIGHTSPatients’ perspectives: “When will I...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCANCER RESEARCH PROGRAM (CRP)RESEARCH HIGHLIGHTSOvercoming the resistance of bladder tumours to...
Congratulations to co-principal investigator Christina Wolfson from the RI-MUHC!
Congratulations to Anish Arora and Motahareh Vameghestahbanati!
Remembering a superb peptide chemist, exceptional collaborator and defender of student welfare
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCHILD HEALTH AND HUMAN DEVELOPMENT (CHHD) PROGRAMRESEARCH HIGHLIGHTS$3.4M for new Centre for...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWBRAIN REPAIR AND INTEGRATIVE NEUROSCIENCE PROGRAM (BRaIN)RESEARCH HIGHLIGHTSA partnership with...
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
RI-MUHC ANNUAL REPORT 2021YOUR SUPPORTTOGETHER WE HAVE THE MEANS TO LEVERAGE DISCOVERIES THAT IMPROVE THE HEALTH OF PATIENTS ACROSS THEIR...
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...
RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCARDIOVASCULAR HEALTH ACROSS THE LIFESPAN (CHAL) PROGRAMRESEARCH HIGHLIGHTSPersonalizing...
RI-MUHC ANNUAL REPORT 2021EXECUTIVE MESSAGESMESSAGE FROM MIGUEL BURNIER JR.During this extraordinary year, the COVID-19 pandemic forced the...
RI-MUHC ANNUAL REPORT 2021FUNDING SUMMARY AND WORLDWIDE NETWORKWe are proud of our researchers’ success in funding competitions and...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWTRANSLATIONAL RESEARCH IN RESPIRATORY DISEASES (RESP) PROGRAMRESEARCH HIGHLIGHTSHarnessing the...
RI-MUHC ANNUAL REPORT 2021THE RI-MUHC IN NUMBERS: 2020-2021 472 active members,including fundamental,clinical and evaluativeresearchers...
RI-MUHC ANNUAL REPORT 2021BUSINESS DEVELOPMENT ACTIVITIESREPURPOSING AN EXISTING DRUG TO TREAT COVID-19Dr. Elena Netchiporouk embarked on a...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWINFECTIOUS DISEASES AND IMMUNITY IN GLOBAL HEALTH (IDIGH) PROGRAMRESEARCH HIGHLIGHTSFirst...